A lack of bioactive predictability for marker compounds commonly used for herbal medicine standardization

Guillermo G. Ruiz, Erik O. Nelson, Adam F. Kozin, Tiffany C. Turner, Robert F. Waters, Jeffrey Langland

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The use of botanical medicine by practitioners and the general public has dramatically increased in recent years. Most of these botanical therapeutics are obtained through commercial manufacturers or nutraceutical companies. The current standard of practice that manufacturers typically use to standardize botanicals is done based on the level of a well-known, abundant marker compound present in the botanical. This study evaluated the putative correlation between the level of a marker compound and the biological activity of eight common botanicals. Overall, the standardization of a botanical based on a marker compound was found not to be a reliable method when compared to in vitro bioactivity. A marker compound is often not the biologically active component of a plant and therefore the level of such a marker compound does not necessarily correlate with biological activity or therapeutic efficacy.

Original languageEnglish (US)
Article numbere0159857
JournalPLoS One
Volume11
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Herbal Medicine
herbal medicines
Bioactivity
standardization
Standardization
bioactive properties
Plant Structures
therapeutics
Dietary Supplements
General Practitioners
functional foods
medicine
Biomarkers
Medicine
Therapeutics
Industry
methodology
In Vitro Techniques

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

A lack of bioactive predictability for marker compounds commonly used for herbal medicine standardization. / Ruiz, Guillermo G.; Nelson, Erik O.; Kozin, Adam F.; Turner, Tiffany C.; Waters, Robert F.; Langland, Jeffrey.

In: PLoS One, Vol. 11, No. 7, e0159857, 01.07.2016.

Research output: Contribution to journalArticle

Ruiz, Guillermo G. ; Nelson, Erik O. ; Kozin, Adam F. ; Turner, Tiffany C. ; Waters, Robert F. ; Langland, Jeffrey. / A lack of bioactive predictability for marker compounds commonly used for herbal medicine standardization. In: PLoS One. 2016 ; Vol. 11, No. 7.
@article{df20c36168b74b96a1ea97c0aa865592,
title = "A lack of bioactive predictability for marker compounds commonly used for herbal medicine standardization",
abstract = "The use of botanical medicine by practitioners and the general public has dramatically increased in recent years. Most of these botanical therapeutics are obtained through commercial manufacturers or nutraceutical companies. The current standard of practice that manufacturers typically use to standardize botanicals is done based on the level of a well-known, abundant marker compound present in the botanical. This study evaluated the putative correlation between the level of a marker compound and the biological activity of eight common botanicals. Overall, the standardization of a botanical based on a marker compound was found not to be a reliable method when compared to in vitro bioactivity. A marker compound is often not the biologically active component of a plant and therefore the level of such a marker compound does not necessarily correlate with biological activity or therapeutic efficacy.",
author = "Ruiz, {Guillermo G.} and Nelson, {Erik O.} and Kozin, {Adam F.} and Turner, {Tiffany C.} and Waters, {Robert F.} and Jeffrey Langland",
year = "2016",
month = "7",
day = "1",
doi = "10.1371/journal.pone.0159857",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - A lack of bioactive predictability for marker compounds commonly used for herbal medicine standardization

AU - Ruiz, Guillermo G.

AU - Nelson, Erik O.

AU - Kozin, Adam F.

AU - Turner, Tiffany C.

AU - Waters, Robert F.

AU - Langland, Jeffrey

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The use of botanical medicine by practitioners and the general public has dramatically increased in recent years. Most of these botanical therapeutics are obtained through commercial manufacturers or nutraceutical companies. The current standard of practice that manufacturers typically use to standardize botanicals is done based on the level of a well-known, abundant marker compound present in the botanical. This study evaluated the putative correlation between the level of a marker compound and the biological activity of eight common botanicals. Overall, the standardization of a botanical based on a marker compound was found not to be a reliable method when compared to in vitro bioactivity. A marker compound is often not the biologically active component of a plant and therefore the level of such a marker compound does not necessarily correlate with biological activity or therapeutic efficacy.

AB - The use of botanical medicine by practitioners and the general public has dramatically increased in recent years. Most of these botanical therapeutics are obtained through commercial manufacturers or nutraceutical companies. The current standard of practice that manufacturers typically use to standardize botanicals is done based on the level of a well-known, abundant marker compound present in the botanical. This study evaluated the putative correlation between the level of a marker compound and the biological activity of eight common botanicals. Overall, the standardization of a botanical based on a marker compound was found not to be a reliable method when compared to in vitro bioactivity. A marker compound is often not the biologically active component of a plant and therefore the level of such a marker compound does not necessarily correlate with biological activity or therapeutic efficacy.

UR - http://www.scopus.com/inward/record.url?scp=84980021939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980021939&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0159857

DO - 10.1371/journal.pone.0159857

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0159857

ER -